Clinical trial

Effect of CAFfeine on Cognition in Alzheimer's Disease

NCT04570085

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2021-03-01

PhasePHASE3

Study timeline

Study start (actual)2021-03-01Date precision: day

Registry last updated2026-04-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

CaffeineDRUG · verified · RxNorm: caffeine

Sponsors & collaborators

University Hospital, Lillelead sponsor

Groupement Interrégional de Recherche Clinique et d'Innovationcollaborator

Laboratory of excellence DISTALZcollaborator

Région Nord-Pas de Calais, Francecollaborator

Meo coffeecollaborator

Mapped research locations

LilleFrance2 CaenFrance1 RouenFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04570085 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.